In particular, research should fully explore the role of DNMT, HDAC, and other potential therapeutic targets identified in the context of heroin rewarding and heroin-seeking behavior in order to determine if these targets might be considered in the research of prescription opioid use disorders. The gene discussed is HDAC9; the disease is opioid use disorder.